Provided is a novel functional composition having an excellent beneficial effect on memory-learning ability that can also be utilized in the form of a food or beverage, etc. Phosphatidylinositol is used as an active ingredient of an oral composition for improving memory-learning ability. The phosphatidylinositol is preferably derived from soybeans. This composition can be used suitably in the form of a food or beverage, food additive, pharmaceutical, supplement, animal feed, etc.

Compositions and methods having antiviral properties, such as for the prevention, treatment or providing nutritional or other benefits in animals, including humans and livestock, having or at risk of viral-mediated disorders. Methods may provide nutritional benefits in a human or animal subject, comprising administering a composition of the present invention. Compositions may comprise monoglycerides and essential oils, including compositions comprising two or more of the following components: a monoglyceride, a curcuminoid, thymoquinone, thymol, carvacrol, and p-cymene. Such viral mediated disorders may be associated with viruses of the family Coronaviridae (e.g., MERS-CoV, SARS-CoV, SARS-CoV-2), viruses of the family Orthomyxoviridae (e.g., Influenza A, Influenza B), Porcine Epidemic Diarrhea Virus, Transmissible Gastroenteritis, Porcine Respiratory Reproductive Syndrome, African Swine Fever Virus, Foot-and-Mouth Virus, Seneca Valley Virus, Influenza A, Avian Influenza H5N1, Rotavirus A, Rotavirus B, Rotavirus C, or Rotavirus D.

Compositions and methods having antiviral properties, such as for the prevention, treatment or providing nutritional or other benefits in animals, including humans and livestock, having or at risk of viral-mediated disorders. Methods may provide nutritional benefits in a human or animal subject, comprising administering a composition of the present invention. Compositions may comprise monoglycerides and essential oils, including compositions comprising two or more of the following components: a monoglyceride, a curcuminoid, thymoquinone, thymol, carvacrol, and p-cymene. Such viral mediated disorders may be associated with viruses of the family Coronaviridae (e.g., MERS-CoV, SARS-CoV, SARS-CoV-2), viruses of the family Orthomyxoviridae (e.g., Influenza A, Influenza B), Porcine Epidemic Diarrhea Virus, Transmissible Gastroenteritis, Porcine Respiratory Reproductive Syndrome, African Swine Fever Virus, Foot-and-Mouth Virus, Seneca Valley Virus, Influenza A, Avian Influenza H5N1, Rotavirus A, Rotavirus B, Rotavirus C, or Rotavirus D.

Bone mineral content, 25(OH) vitamin D3, or 1,25(OH).sub.2 vitamin D3 in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the bone mineral content, 25(OH) vitamin D3, or 1,25(OH).sub.2 vitamin D3 or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the bone mineral content, 25(OH) vitamin D3, or 1,25(OH).sub.2 vitamin D3.

Bone mineral content, 25(OH) vitamin D3, or 1,25(OH).sub.2 vitamin D3 in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the bone mineral content, 25(OH) vitamin D3, or 1,25(OH).sub.2 vitamin D3 or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the bone mineral content, 25(OH) vitamin D3, or 1,25(OH).sub.2 vitamin D3.

The present invention relates to compositions that can be used as effective agents for prevention and protection of feed ingredients, particularly from mold growth, and methods for preparing the same. Another aspect relates to compositions containing synergistic combinations of propionic esters, free propionic acid, and propionic salts, capable of protecting against mold proliferation. Another aspect of the present invention relates to providing a user-friendly, non-corrosive approach for controlling mold growth in animal feed.

The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.

This invention is directed to compositions and methods to detect and treat gastrointestinal diseases.

This invention is directed to compositions and methods to detect and treat gastrointestinal diseases.

The presently disclosed subject matter provides methods of preparing wet food products, such as jellified wet food products. Methods include preparing a pre-gel mixture comprising a combination of food ingredients, one or more alginate, and an aqueous liquid; adding one or more organic acids to the pre-gel mixture to generate a jellified composition; and expulsing aqueous liquid within the jellified composition. The present disclosure further provides microbially stable wet food products prepared using such methods.